FilingSEC EDGAR6-K
Polyrizon Files for New U.S. Patent for Intranasal Drug-Delivery Platform
· SEC accepted
StagePatent Filing
Filing content
Polyrizon announced the filing of a new U.S. divisional patent application to expand intellectual property protection for its proprietary mucoadhesive technology.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…